stockrowDENTSPLY SIRONA Inc.
XRAY Healthcare Medical Instruments & Supplies
DENTSPLY SIRONA Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, down 2.98% from fiscal 2024.
- Revenue
- −7.52%
- EPS
- +99.5%
- Free cash flow
- −18.0%
- Total debt
- −1.59%
Quarter to September 2026, against a year earlier
Follow XRAY
Alert me
DENTSPLY SIRONA Inc. (XRAY) Shares outstanding
DENTSPLY SIRONA Inc.'s shares outstanding at the end of fiscal 2025 was $199.4M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $199.2M. Over the past ten years it has ranged from $142.5M (fiscal 2015) to $229.4M (fiscal 2017); the current reading is higher than 18% of that period. DENTSPLY SIRONA Inc. ranks 10th of 47 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $199.4M | (1.87%) |
| FY2024 | $203.2M | (4.15%) |
| FY2023 | $212.0M | (1.62%) |
| FY2022 | $215.5M | (2.13%) |
| FY2021 | $220.2M | 0.46% |
| FY2020 | $219.2M | (2.32%) |
| FY2019 | $224.4M | 0.04% |
| FY2018 | $224.3M | (2.22%) |
| FY2017 | $229.4M | 3.52% |
| FY2016 | $221.6M | 55.51% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $199.2M | (0.65%) |
| Jun 2026 | $200.5M | 0.30% |
| Mar 2026 | $199.9M | 0.25% |
| Dec 2025 | $199.4M | (0.05%) |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| STVN Stevanato Group S.p.A. compare | $273.1M |
| XRAY DENTSPLY SIRONA Inc. | $199.2M |
| WRBY Warby Parker Inc. compare | $126.1M |
| PLSE Pulse Biosciences, Inc compare | $71.9M |
| KMTS Kestra Medical Technologies, Ltd. compare | $58.6M |
| STAA STAAR Surgical Company compare | $51.4M |
| ATRC AtriCure, Inc. compare | $49.8M |
| AZTA Azenta, Inc. compare | $45.3M |
| LMAT LeMaitre Vascular, Inc. compare | $23.1M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on XRAY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement